Devices › Device types
FDA product code DRS · class 2 · Cardiovascular
Transducer, blood-pressure, extravascular: medical device reports filed with FDA
3,916 reports carry this product code, 1993–2026; 12 brands with a page.
- 3,916
- reports with this product code
- 0% of all MAUDE reports
- 177
- reports, 12 months to August 2026
- 195 in the 12 months before
- 89.6%
- classified as malfunction
- 62.3% across all reports
- 0.6%
- classified as death, as reported
- 0.9% across all reports
Product code DRS is FDA's classification for "Transducer, blood-pressure, extravascular" (cardiovascular panel), a class 2 device. 3,916 medical device reports carry this product code, 0% of the MAUDE database, from August 1993 to August 2026.
177 reports arrived in the 12 months to August 2026, close to the 195 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (89.6%), injury (6.4%) and other (2.5%). 12 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| TruWave Disposable Pressure Transducer | 382 | 67 | 0.5% | 96.5% |
| FloTrac Sensor | 184 | 10 | 0% | 96.9% |
| Pressure Monitoring Kit | 22 | 0 | 0.7% | 90.4% |
| ICU Medical | 20 | 55 | 0.3% | 97.2% |
| Boston Scientific | 13 | 5 | 3.3% | 55% |
| Abbott | 6 | 0 | 7.5% | 52.1% |
| Medex | 6 | 8 | 0% | 81.7% |
| AngioDynamics | 4 | 14 | 1.7% | 82.2% |
| Safedraw | 4 | 85 | 0% | 97.7% |
| Transtar | 2 | 0 | 0% | 99.4% |
| Cardiosave Hybrid Type B Plug | 1 | 2,631 | 0.4% | 99.3% |
| Trans-Ray Plus 7 5 Fr 40cc Iab | 1 | 0 | 0.3% | 98.8% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Edwards Lifesciences | 737 | 18.8% |
| Icu Medical De Mexico S De R L De C V | 668 | 17.1% |
| Medex | 356 | 9.1% |
| Icu Medical | 269 | 6.9% |
| Abbott Laboratories | 245 | 6.3% |
| Smiths Medical Asd | 155 | 4% |
| Smiths Medical | 88 | 2.2% |
| Hospira | 72 | 1.8% |
| Smiths Medical International | 43 | 1.1% |
| Edwards Lifesciences Pr | 20 | 0.5% |
| Merit Medical Systems | 18 | 0.5% |
| Argon Medical Devices | 12 | 0.3% |
| Hospira Costa Rica | 10 | 0.3% |
| Icu Medical Healthcare Manufacturing De C V | 8 | 0.2% |
| Datascope | 3 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Detachment of device component | 475 | 12.1% |
| Fluid/blood leak | 405 | 10.3% |
| Leak/splashthe device leaked | 391 | 10% |
| Breakthe device broke | 318 | 8.1% |
| Material separation | 313 | 8% |
| Disconnection | 266 | 6.8% |
| Crackthe device cracked | 179 | 4.6% |
| Replace | 175 | 4.5% |
| Air leak | 167 | 4.3% |
| Incorrect, inadequate or imprecise result or readings | 93 | 2.4% |
| Component(s), broken | 74 | 1.9% |
| Incorrect measurementthe device measured wrongly | 58 | 1.5% |
| Backflow | 56 | 1.4% |
| Contamination | 52 | 1.3% |
| Unable to obtain readings | 50 | 1.3% |
| Loose or intermittent connection | 47 | 1.2% |
| Drift | 44 | 1.1% |
| Air/gas in device | 41 | 1% |
| Excess flow or over-infusion | 39 | 1% |
| Cut in material | 36 | 0.9% |
Questions about transducer, blood-pressure, extravascular reports
What is product code DRS?
FDA's classification code for "Transducer, blood-pressure, extravascular", class 2, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.
How many reports carry this code?
3,916 reports through August 2026, 177 of them in the latest 12 months.
Which brands appear most often?
TruWave Disposable Pressure Transducer (382), FloTrac Sensor (184), Pressure Monitoring Kit (22), ICU Medical (20) and Boston Scientific (13). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.